C1orf174
geneOn this page
Also known as RP13-531C17.2
Summary
C1orf174 (chromosome 1 open reading frame 174, HGNC:27915) is a protein-coding gene on chromosome 1p36.32, encoding UPF0688 protein C1orf174 (Q8IYL3).
Located in nucleoplasm.
Source: NCBI Gene 339448 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 18 total — 2 pathogenic
- MANE Select transcript:
NM_207356
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:27915 |
| Approved symbol | C1orf174 |
| Name | chromosome 1 open reading frame 174 |
| Location | 1p36.32 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | RP13-531C17.2 |
| Ensembl gene | ENSG00000198912 |
| Ensembl biotype | protein_coding |
| Entrez | 339448 |
Gene structure
Transcript identifiers
Ensembl transcripts: 11 — 5 nonsense_mediated_decay, 3 protein_coding, 2 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000361605, ENST00000474140, ENST00000486765, ENST00000679703, ENST00000679929, ENST00000679946, ENST00000680054, ENST00000680169, ENST00000680279, ENST00000680535, ENST00000681823
RefSeq mRNA: 1 — MANE Select: NM_207356
NM_207356
CCDS: CCDS53
Canonical transcript exons
ENST00000361605 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001891341 | 3900172 | 3900272 |
| ENSE00003466374 | 3890569 | 3891057 |
| ENSE00003548802 | 3892883 | 3892996 |
| ENSE00003665457 | 3889133 | 3890073 |
Expression profiles
Bgee: expression breadth ubiquitous, 281 present calls, max score 98.21.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 19.8755 / max 108.5483, expressed in 1813 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 9966 | 19.8755 | 1813 |
Top tissues by expression
286 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| oocyte | CL:0000023 | 98.21 | gold quality |
| secondary oocyte | CL:0000655 | 96.54 | gold quality |
| gingival epithelium | UBERON:0001949 | 89.91 | gold quality |
| skin of hip | UBERON:0001554 | 89.87 | gold quality |
| blood vessel layer | UBERON:0004797 | 88.81 | gold quality |
| nephron tubule | UBERON:0001231 | 88.78 | gold quality |
| hair follicle | UBERON:0002073 | 88.25 | gold quality |
| granulocyte | CL:0000094 | 88.04 | gold quality |
| upper leg skin | UBERON:0004262 | 87.86 | gold quality |
| gingiva | UBERON:0001828 | 87.83 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 87.78 | gold quality |
| colonic mucosa | UBERON:0000317 | 87.52 | gold quality |
| pylorus | UBERON:0001166 | 87.19 | gold quality |
| urethra | UBERON:0000057 | 87.15 | gold quality |
| seminal vesicle | UBERON:0000998 | 87.09 | gold quality |
| saphenous vein | UBERON:0007318 | 87.01 | gold quality |
| renal glomerulus | UBERON:0000074 | 86.94 | gold quality |
| renal medulla | UBERON:0000362 | 86.76 | gold quality |
| penis | UBERON:0000989 | 86.65 | gold quality |
| synovial joint | UBERON:0002217 | 86.63 | gold quality |
| right lobe of liver | UBERON:0001114 | 86.55 | gold quality |
| superficial temporal artery | UBERON:0001614 | 86.55 | gold quality |
| spleen | UBERON:0002106 | 86.51 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 86.51 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 86.39 | gold quality |
| metanephric glomerulus | UBERON:0004736 | 86.37 | gold quality |
| duodenum | UBERON:0002114 | 86.36 | gold quality |
| superior surface of tongue | UBERON:0007371 | 86.33 | gold quality |
| oviduct epithelium | UBERON:0004804 | 86.31 | gold quality |
| lower esophagus | UBERON:0013473 | 86.30 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 7.17 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
43 targeting C1orf174, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-4455 | 100.00 | 65.48 | 1587 |
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-513B-5P | 99.99 | 69.96 | 2150 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-1468-3P | 99.96 | 72.74 | 3797 |
| HSA-MIR-450B-5P | 99.92 | 71.48 | 3175 |
| HSA-MIR-8063 | 99.91 | 69.76 | 3146 |
| HSA-MIR-1305 | 99.91 | 71.43 | 3443 |
| HSA-MIR-4698 | 99.84 | 71.41 | 4303 |
| HSA-MIR-8080 | 99.82 | 67.52 | 1342 |
| HSA-MIR-548AJ-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-548F-5P | 99.78 | 71.02 | 3093 |
| HSA-MIR-548G-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-548X-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-518A-5P | 99.70 | 69.01 | 2209 |
| HSA-MIR-527 | 99.70 | 69.01 | 2209 |
| HSA-MIR-6892-3P | 99.68 | 66.40 | 1178 |
| HSA-MIR-646 | 99.68 | 67.84 | 1645 |
| HSA-MIR-1251-3P | 99.64 | 67.21 | 1408 |
| HSA-MIR-4452 | 99.50 | 68.45 | 1493 |
| HSA-MIR-12131 | 99.48 | 68.72 | 1673 |
| HSA-MIR-569 | 99.42 | 66.32 | 1009 |
| HSA-MIR-4666A-5P | 99.41 | 69.72 | 1887 |
| HSA-MIR-297 | 99.40 | 69.58 | 1418 |
| HSA-MIR-4426 | 99.17 | 66.74 | 1949 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | si:ch211-147a11.3 | ENSDARG00000069009 |
| mus_musculus | A430005L14Rik | ENSMUSG00000047613 |
| rattus_norvegicus | C5h1orf174 | ENSRNOG00000025034 |
Protein
Protein identifiers
UPF0688 protein C1orf174 — Q8IYL3 (reviewed: Q8IYL3)
All UniProt accessions (7): Q8IYL3, A0A7P0T887, A0A7P0T8I3, A0A7P0T8M5, A0A7P0TAC3, A0A7P0TAV4, A0A7P0Z4H8
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Nucleus.
Similarity. Belongs to the UPF0688 family.
RefSeq proteins (1): NP_997239* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR031530 | UPF0688 | Family |
Pfam: PF15772
UniProt features (10 total): sequence variant 3, region of interest 2, compositionally biased region 2, modified residue 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8IYL3-F1 | 61.92 | 0.06 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 148, 189
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 119 (showing top):
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP, FISCHER_DREAM_TARGETS, HAN_SATB1_TARGETS_DN, MARSON_BOUND_BY_E2F4_UNSTIMULATED, MULLIGHAN_MLL_SIGNATURE_1_DN, chr1p36, JOHNSTONE_PARVB_TARGETS_3_DN, GCNP_SHH_UP_LATE.V1_UP, ATF5_TARGET_GENES, CIITA_TARGET_GENES, COBLL1_TARGET_GENES, E2F2_TARGET_GENES, E2F5_TARGET_GENES, HES2_TARGET_GENES, NFE2L1_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (2): nucleoplasm (GO:0005654), nucleus (GO:0005634)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| nuclear lumen | 1 |
| cellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
538 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| C1orf174 | CCDC27 | Q2M243 | 575 |
| C1orf174 | CEP104 | O60308 | 506 |
| C1orf174 | MRPS16 | Q9Y3D3 | 494 |
| C1orf174 | HAGHL | Q6PII5 | 447 |
| C1orf174 | LRRC47 | Q8N1G4 | 447 |
| C1orf174 | PPP1R2C | O14990 | 393 |
| C1orf174 | SPANXN1 | Q5VSR9 | 390 |
| C1orf174 | DENND10 | Q8TCE6 | 379 |
| C1orf174 | EFCAB14 | O75071 | 377 |
| C1orf174 | BRD10 | Q5HYC2 | 374 |
| C1orf174 | CXorf38 | Q8TB03 | 370 |
| C1orf174 | TPRG1L | Q5T0D9 | 370 |
| C1orf174 | SPATA25 | Q9BR10 | 370 |
| C1orf174 | ARL16 | Q0P5N6 | 357 |
| C1orf174 | OSER1 | Q9NX31 | 354 |
IntAct
47 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| C1orf174 | PDIK1L | psi-mi:“MI:0915”(physical association) | 0.900 |
| PDIK1L | CTDSPL2 | psi-mi:“MI:0914”(association) | 0.840 |
| C1orf174 | IKZF1 | psi-mi:“MI:0915”(physical association) | 0.670 |
| IKZF1 | C1orf174 | psi-mi:“MI:0915”(physical association) | 0.670 |
| DCK | DGUOK | psi-mi:“MI:0914”(association) | 0.620 |
| IKZF1 | C1orf174 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MEOX2 | C1orf174 | psi-mi:“MI:0915”(physical association) | 0.560 |
| STK35 | HSP90AA1 | psi-mi:“MI:0914”(association) | 0.530 |
| C1orf174 | AHCYL1 | psi-mi:“MI:0914”(association) | 0.530 |
| C1orf174 | TERF2IP | psi-mi:“MI:0915”(physical association) | 0.510 |
| C1orf174 | SRPK2 | psi-mi:“MI:0217”(phosphorylation reaction) | 0.440 |
| H3C1 | SMCHD1 | psi-mi:“MI:2364”(proximity) | 0.410 |
| C1orf174 | MYH9 | psi-mi:“MI:0915”(physical association) | 0.400 |
| Xpo1 | IFT56 | psi-mi:“MI:0914”(association) | 0.350 |
| PDIK1L | HSP90AA1 | psi-mi:“MI:0914”(association) | 0.350 |
| STK35 | HSP90AA1 | psi-mi:“MI:0914”(association) | 0.350 |
| PDIK1L | CSTB | psi-mi:“MI:0914”(association) | 0.350 |
| C1orf174 | H2AC11 | psi-mi:“MI:0914”(association) | 0.350 |
| EGLN3 | KLK3 | psi-mi:“MI:0914”(association) | 0.350 |
| C1orf174 | POLRMT | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (65): C1orf174 (Two-hybrid), C1orf174 (Two-hybrid), C1orf174 (Affinity Capture-MS), C1orf174 (Affinity Capture-MS), C1orf174 (Affinity Capture-MS), C1orf174 (Affinity Capture-MS), C1orf174 (Affinity Capture-MS), C1orf174 (Proximity Label-MS), C1orf174 (Affinity Capture-MS), C1orf174 (Two-hybrid), COPS6 (Two-hybrid), EEF1G (Two-hybrid), KAT5 (Two-hybrid), C1orf174 (Two-hybrid), C1orf174 (Two-hybrid)
ESM2 similar proteins: A0A087WXM9, A0A2K1JJ00, A0JM83, A4IGL8, E1BC15, E9Q5F9, O14513, O35923, O60673, O88491, P46013, P97929, Q14B71, Q28DZ0, Q29RT4, Q3MHH3, Q3TNU4, Q3ZBP0, Q4QY64, Q4V7J0, Q5DTT3, Q5E9A0, Q5F2C3, Q5RD08, Q5VWN6, Q5VYV7, Q61493, Q69YH5, Q6NS59, Q703I1, Q80U59, Q86XD8, Q8IXS0, Q8IYL3, Q8L7I1, Q8N7Z5, Q8NFU7, Q8TEP8, Q92628, Q96BU1
Diamond homologs: A0JM83, Q1L9C7, Q32PF7, Q3KQW6, Q5M951, Q80WR5, Q8IYL3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
18 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 2 |
| Likely pathogenic | 0 |
| Uncertain significance | 9 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (2)
| Variant ID | HGVS | Classification |
|---|---|---|
| 144175 | GRCh38/hg38 1p36.32(chr1:3712088-4027367)x4 | Pathogenic |
| 974581 | Single allele | Pathogenic |
SpliceAI
460 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:3890075:T:C | acceptor_gain | 1.0000 |
| 1:3900166:CCTCA:C | donor_loss | 1.0000 |
| 1:3900167:CTCAC:C | donor_loss | 1.0000 |
| 1:3900168:TCAC:T | donor_loss | 1.0000 |
| 1:3900169:CACC:C | donor_loss | 1.0000 |
| 1:3890073:CCT:C | acceptor_gain | 0.9900 |
| 1:3890078:G:GC | acceptor_gain | 0.9900 |
| 1:3891053:GAAGT:G | acceptor_gain | 0.9900 |
| 1:3891058:C:CC | acceptor_gain | 0.9900 |
| 1:3900174:T:TA | donor_gain | 0.9900 |
| 1:3890563:TCTTA:T | donor_loss | 0.9800 |
| 1:3890564:CTTA:C | donor_loss | 0.9800 |
| 1:3890565:TTA:T | donor_loss | 0.9800 |
| 1:3890566:TACC:T | donor_loss | 0.9800 |
| 1:3890568:C:A | donor_loss | 0.9800 |
| 1:3891056:GT:G | acceptor_gain | 0.9800 |
| 1:3891057:TCT:T | acceptor_loss | 0.9800 |
| 1:3900170:A:AC | donor_gain | 0.9800 |
| 1:3900170:ACCTT:A | donor_gain | 0.9800 |
| 1:3900171:C:CC | donor_gain | 0.9800 |
| 1:3900171:CCTT:C | donor_gain | 0.9800 |
| 1:3900171:CCTTC:C | donor_gain | 0.9800 |
| 1:3890072:TCC:T | acceptor_loss | 0.9700 |
| 1:3890073:CC:C | acceptor_loss | 0.9700 |
| 1:3890074:C:CC | acceptor_gain | 0.9700 |
| 1:3890074:CTT:C | acceptor_loss | 0.9700 |
| 1:3890075:T:TC | acceptor_gain | 0.9700 |
| 1:3890078:G:C | acceptor_gain | 0.9700 |
| 1:3891055:AGT:A | acceptor_gain | 0.9700 |
| 1:3892920:T:TA | donor_gain | 0.9700 |
AlphaMissense
1596 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:3890008:G:C | F228L | 0.998 |
| 1:3890008:G:T | F228L | 0.998 |
| 1:3890010:A:G | F228L | 0.998 |
| 1:3890020:T:A | R224S | 0.998 |
| 1:3890020:T:G | R224S | 0.998 |
| 1:3890021:C:G | R224T | 0.998 |
| 1:3890009:A:G | F228S | 0.996 |
| 1:3890013:G:C | H227D | 0.996 |
| 1:3890021:C:A | R224I | 0.996 |
| 1:3890594:A:G | F198S | 0.996 |
| 1:3890620:G:C | S189R | 0.995 |
| 1:3890620:G:T | S189R | 0.995 |
| 1:3890622:T:G | S189R | 0.995 |
| 1:3890590:A:C | F199L | 0.994 |
| 1:3890590:A:T | F199L | 0.994 |
| 1:3890592:A:G | F199L | 0.994 |
| 1:3890593:G:C | F198L | 0.993 |
| 1:3890593:G:T | F198L | 0.993 |
| 1:3890595:A:G | F198L | 0.993 |
| 1:3890022:T:C | R224G | 0.992 |
| 1:3890032:T:A | R220S | 0.992 |
| 1:3890032:T:G | R220S | 0.992 |
| 1:3890009:A:C | F228C | 0.991 |
| 1:3890033:C:G | R220T | 0.991 |
| 1:3890011:A:C | H227Q | 0.988 |
| 1:3890011:A:T | H227Q | 0.988 |
| 1:3890035:G:C | S219R | 0.988 |
| 1:3890035:G:T | S219R | 0.988 |
| 1:3890037:T:G | S219R | 0.988 |
| 1:3889999:T:A | K231N | 0.987 |
dbSNP variants (sampled 300 via entrez): RS1000177534 (1:3891773 T>A,C), RS1000256530 (1:3900384 G>C,T), RS1000329359 (1:3897389 A>G), RS1000386651 (1:3897049 G>A), RS1000543148 (1:3901240 C>A,T), RS1000998172 (1:3896751 T>C), RS1001133448 (1:3897008 T>C), RS1001236082 (1:3893412 A>T), RS1001388692 (1:3898202 T>C), RS1001949083 (1:3902177 C>A,T), RS1002172475 (1:3894707 T>C), RS1002374851 (1:3899547 C>T), RS1002525992 (1:3894030 A>G), RS1002631261 (1:3894424 A>G,T), RS1002952320 (1:3894242 T>A,C)
Disease associations
OMIM: gene `` | disease phenotypes: MIM:607872
GenCC curated gene-disease
Mondo (2): chromosome 1p36 deletion syndrome (MONDO:0011929), megacolon (MONDO:0001273)
Orphanet (1): 1p36 deletion syndrome (Orphanet:1606)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002701_10 | Verbal declarative memory | 3.000000e-06 |
| GCST002701_34 | Verbal declarative memory | 3.000000e-07 |
| GCST002701_9 | Verbal declarative memory | 2.000000e-06 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004874 | memory performance |
| EFO:0006805 | word list delayed recall measurement |
MeSH disease descriptors (2)
| Descriptor | Name | Tree numbers |
|---|---|---|
| D008531 | Megacolon | C06.405.469.158.701 |
| C535362 | Chromosome 1p36 Deletion Syndrome (supp.) |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
27 total (human), top 27 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, increases expression, increases methylation | 4 |
| sodium arsenite | decreases expression, increases abundance | 2 |
| Arsenic | affects methylation, decreases expression, increases abundance | 2 |
| GSK-J4 | increases expression | 1 |
| coumarin | decreases phosphorylation | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| ICG 001 | increases expression | 1 |
| abrine | decreases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Temozolomide | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Vorinostat | increases expression | 1 |
| Leflunomide | decreases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Caffeine | increases phosphorylation | 1 |
| Diazinon | increases methylation | 1 |
| Diuron | decreases expression | 1 |
| Enzyme Inhibitors | decreases activity, increases O-linked glycosylation | 1 |
| Formaldehyde | decreases expression | 1 |
| Ketoconazole | increases expression | 1 |
| Thimerosal | increases expression | 1 |
| Thiram | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Cadmium Chloride | increases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
4 trials via MONDO — disease-level, not drug-specific.
| Trial | Phase | Status | Title |
|---|---|---|---|
| NCT01793168 | Not specified | RECRUITING | Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford |
| NCT02381457 | Not specified | COMPLETED | SNP-based Microdeletion and Aneuploidy RegisTry (SMART) |
| NCT04340856 | Not specified | COMPLETED | Retrospective, Uncontrolled Cohort Study on the Therapy of Chronic Megalon |
| NCT07470892 | Not specified | NOT_YET_RECRUITING | Preoperative Fish Oil PN and Prognosis After Constipation Surgery |
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): chromosome 1p36 deletion syndrome, megacolon